Investor Relations

Company Overview

Keenova Therapeutics is a leading global developer and manufacturer of branded therapeutics that strives to help patients with rare or unaddressed conditions live happier and healthier lives.

Keenova’s rare disease capabilities underpin our diversified brands portfolio, which is focused across a wide range of therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, orthopedics, urology, neonatal respiratory critical care, nephrology, neurology, and pulmonology.

Visit Keenova

Transaction Info

More information is coming soon.

For equity transfer and settlement questions, contact:
Georgeson
Toll Free: (866) 585-7241 |  Outside the US: (310) 853-6676
Email: mallexchange@georgeson.com

All other questions: investor.relations@mnk.com